Resumo

SCHWAB, Marcos et al. Defective nitric oxide homeostasis: Common underlying mechanism between insulin resistance, sympathetic overactivity and cardiovascular morbidity and mortality. Medicina (B. Aires) [online]. 2008, vol.68, n.3, pp.243-250. ISSN 0025-7680.

Obesity, insulin resistance and associated cardiovascular complications are reaching epidemic proportions worldwide and represent a major public health problem. Over the past decade, evidence has accumulated indicating that insulin administration, in addition to its metabolic effects, also has important cardiovascular actions. The sympathetic nervous system and the L-arginine-nitric oxide pathway are the central players in the mediation of insulin's cardiovascular actions. Based on recent animal and human research, we demonstrate that both defective and augmented NO synthesis represent a central defect triggering many of the metabolic, vascular and sympathetic abnormalities characteristic of insulin-resistant states. These observations provide the rationale for the use of pharmaceutical drugs releasing small and physiological amounts of NO and/or inhibitors of NO overproduction as a future treatment for insulin resistance and associated comorbidities.

Palavras-chave : Insulin resistance; Nitric oxide; Endothelium; Hypertension; Autonomic nervous system; Mitochondria.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )